Cargando…
High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elder...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338816/ https://www.ncbi.nlm.nih.gov/pubmed/22558116 http://dx.doi.org/10.1371/journal.pone.0035059 |
_version_ | 1782231270678331392 |
---|---|
author | Mingels, Alma M. Joosen, Ivo A. Versteylen, Mathijs O. Laufer, Eduard M. Winkens, Mark H. Wildberger, Joachim E. Van Dieijen-Visser, Marja P. Hofstra, Leonard |
author_facet | Mingels, Alma M. Joosen, Ivo A. Versteylen, Mathijs O. Laufer, Eduard M. Winkens, Mark H. Wildberger, Joachim E. Van Dieijen-Visser, Marja P. Hofstra, Leonard |
author_sort | Mingels, Alma M. |
collection | PubMed |
description | BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. METHODS: We studied 1,088 patients (follow-up 2.2±0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. RESULTS: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88–6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus <Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. CONCLUSIONS: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results. |
format | Online Article Text |
id | pubmed-3338816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33388162012-05-03 High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort Mingels, Alma M. Joosen, Ivo A. Versteylen, Mathijs O. Laufer, Eduard M. Winkens, Mark H. Wildberger, Joachim E. Van Dieijen-Visser, Marja P. Hofstra, Leonard PLoS One Research Article BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. METHODS: We studied 1,088 patients (follow-up 2.2±0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. RESULTS: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88–6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus <Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. CONCLUSIONS: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results. Public Library of Science 2012-04-25 /pmc/articles/PMC3338816/ /pubmed/22558116 http://dx.doi.org/10.1371/journal.pone.0035059 Text en Mingels et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Mingels, Alma M. Joosen, Ivo A. Versteylen, Mathijs O. Laufer, Eduard M. Winkens, Mark H. Wildberger, Joachim E. Van Dieijen-Visser, Marja P. Hofstra, Leonard High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title | High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title_full | High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title_fullStr | High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title_full_unstemmed | High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title_short | High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort |
title_sort | high-sensitivity cardiac troponin t: risk stratification tool in patients with symptoms of chest discomfort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338816/ https://www.ncbi.nlm.nih.gov/pubmed/22558116 http://dx.doi.org/10.1371/journal.pone.0035059 |
work_keys_str_mv | AT mingelsalmam highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT joosenivoa highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT versteylenmathijso highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT laufereduardm highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT winkensmarkh highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT wildbergerjoachime highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT vandieijenvissermarjap highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort AT hofstraleonard highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort |